Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-Label Rollover Study for Continuing NBI-98854 Administration for the Treatment of Pediatric Subjects With Tourette Syndrome

NCT03732534 is registered in ClinicalTrials.gov with Neurocrine Biosciences as lead sponsor.

NCT NCT03732534
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03732534 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-Label Rollover Study for Continuing NBI-98854 Administration for the Treatment of Pediatric Subjects With Tourette Syndrome
Lead sponsor
Neurocrine Biosciences
Phase
Phase 2
Overall status
Terminated
Start date
October 17, 2018
Completion date
February 18, 2019
Enrollment
6 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

tourette syndrome